Ethicon Endo-Surgery, Inc.Download PDFPatent Trials and Appeals BoardJul 28, 20202020000017 (P.T.A.B. Jul. 28, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/974,202 08/23/2013 David C. Yates END7295USNP/130018 1078 92223 7590 07/28/2020 K&L GATES LLP - ETHICON K&L GATES CENTER 210 SIXTH AVENUE PITTSBURGH, PA 15222-2613 EXAMINER FRY, PATRICK B ART UNIT PAPER NUMBER 3731 NOTIFICATION DATE DELIVERY MODE 07/28/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): uspatentmail@klgates.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte DAVID C. YATES, FREDERICK E. SHELTON IV, and KEVIN L. HOUSER Appeal 2020-000017 Application 13/974,202 Technology Center 3700 ____________ Before MICHAEL J. FITZPATRICK, JILL D. HILL, and LEE L. STEPINA, Administrative Patent Judges. FITZPATRICK, Administrative Patent Judge. DECISION ON APPEAL Appellant1 appeals under 35 U.S.C. § 134(a) from the Examiner’s final decision rejecting claims 1, 2, and 5–21. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 “Appellant” refers to the applicant as defined in 37 C.F.R. § 1.42. Appellant identifies Ethicon LLC as the sole real party in interest. Appeal Br. 2. Appeal 2020-000017 Application 13/974,202 2 STATEMENT OF THE CASE The Specification The Specification “relates to surgical instruments and, in various arrangements, to powered surgical cutting and stapling instruments and staple cartridges therefor that are designed to cut and staple tissue.” Spec. ¶1. The Claims Claims 1, 2, and 5–21 are rejected. Final Act. 1. No other claims are pending. Id. There are four independent claims: claims 1, 9, 17, and 21. Claim 1 is illustrative and reproduced below. 1. A surgical instrument system, comprising: a surgical instrument comprising a controller; a first end effector selectively attachable to said surgical instrument; a second end effector selectively attachable to said surgical instrument, wherein said second end effector comprises: a memory, comprising: a first stored datum regarding a first parameter of said second end effector; a second stored datum regarding a second parameter of said second end effector; and a stored checksum value; means for communicating said first stored datum to said surgical instrument while said second end effector is attached to said surgical instrument; means for communicating said second stored datum to said surgical instrument while said second end effector is attached to said surgical instrument; Appeal 2020-000017 Application 13/974,202 3 means for communicating said stored checksum value to said surgical instrument while said second end effector is attached to said surgical instrument, wherein said surgical instrument is configured to calculate a calculated checksum value utilizing at least said first stored datum and said second stored datum, wherein said surgical instrument is configured to compare said calculated checksum value to said stored checksum value, and wherein said surgical instrument is configured to generate an error response if said calculated checksum value does not match said stored checksum value; and a staple firing system configured to perform a staple firing stroke, wherein said staple firing system is in communication with said controller, and wherein said error response comprises said controller operating said staple firing system in an operating mode which is suitable regardless of whether said first end effector or said second end effector is attached to the surgical instrument in order to perform said staple firing stroke. Appeal Br. 28–29. The Examiner’s Rejections The rejections before us, all pursuant to 35 U.S.C. § 103, are: 1. claims 1, 2, 5, 9, 10, 13, and 21 as unpatentable over Smith2 and Turner3 (Final Act. 2); 2. claims 11 and 12 as unpatentable over Smith, Turner, and Hueil4 (id. at 10); 2 US 2009/0057369 A1, published Mar. 5, 2009 (“Smith”). 3 US 7,987,405 B2, issued July 26, 2011 (“Turner”). 4 US 2009/0206132 A1, published, Aug. 20, 2009 (“Hueil”). Appeal 2020-000017 Application 13/974,202 4 3. claims 6 and 14 as unpatentable over Smith, Turner, and Analog Dialogue5 (id. at 12); and 4. claims 7, 8, and 15–20 as unpatentable over Smith, Turner, Analog Dialogue, and Protocol6 (id.). DISCUSSION Rejection 1 The Examiner rejected claims 1, 2, 5, 9, 10, 13, and 21 as unpatentable over Smith and Turner. Final Act. 2. Appellant argues against the rejection of independent claim 1 and dependent claims 2, 5, 10, and 13 together. Appeal Br. 18–23. For these claims, we choose claim 1 as representative. 37 C.F.R. § 41.37(c)(1)(iv). Appellant argues against the rejection of independent claims 9 and 21 under a separate heading, but, in doing so, Appellant relies exclusively on its arguments with respect to claim 1. Appeal Br. 23–24. Accordingly, we resolve the entire rejection based on claim 1. Smith discloses “[a]n electrically operated surgical instrument [that] includes a surgical end effector having an actuation assembly effecting a surgical procedure when actuated and a handle connected to the end effector for actuating the assembly.” Smith, Abstract. The Examiner found that Smith discloses the subject matter of claim 1 save the limitations directed to using a “checksum” for determining whether an “error” exists. Final Act. 2– 5 David Katz et al., Fast, Versatile Blackfin® Processors Handle Advanced RFID Reader Applications, 40 ANALOG DIALOGUE (Sept. 2006) (“Analog Dialogue”). 6 https://web.archive.org/web/20120429111451 (http://www.nd.edu/~ lemmon/courses/ee224/web-manual/web-manual/lab12/node2.html) [visited 2/1/2016 10:28:32 AM] (“Protocol”). Appeal 2020-000017 Application 13/974,202 5 4 (citing Smith ¶¶108, 141, 174, 181, 183). Smith teaches a protocol for verifying/authenticating an end effector but that protocol does not employ a checksum. For example, Smith discloses the following: [W]here a medical stapler uses re-loadable, interchangeable staple cartridges, such as the stapler 1 described herein, an RFID can be placed in the staple cartridge to ensure compatibility with the particular stapler and an RFID reader for sensing compatible staple cartridges can be associated with the handle. In such a configuration, the reader interrogates the RFID mounted in the cartridge. The RFID responds with a unique code that the stapler verifies. If the stapler cartridge is labeled as verified, the stapler becomes active and ready for use. Smith ¶174. However, the Examiner found that Turner teaches “calculating and verifying the integrity of data transmitted by a RFID system” in which (1) data and a checksum is transmitted from a remote station to a base station, (2) the base station calculates a calculated checksum from the data, and (3) the base station compares the calculated checksum to the transmitted checksum. Final Act. 4–5 (citing Turner 1:16–32, 2:9–23). The Examiner found that Turner’s verification routine “would be beneficial to incorporate into [Smith’s] system because it would provide the surgical instrument with a means to verify the integrity of the data from the end effector.” Id. at 5. The Examiner concluded: [I]t would have been obvious to the person of ordinary skill in the art, before the effective filling date of the applicant's claimed invention, to have modified Smith et al. by incorporating the method of verifying integrity of data as taught by Turner et al. because the person of ordinary skill in the art would know that by providing the surgical instrument with a means to verify the integrity of the data from the end effector would make the system more reliable and therefore better. Appeal 2020-000017 Application 13/974,202 6 Id. Appellant first argues that Smith’s “authentication protocol is not a checksum.” Appeal Br. 21. This argument is inapposite to the Examiner’s rejection, which, as discussed above, does not rely on Smith for the “checksum” limitations. See In re Merck & Co., 800 F.2d 1091, 1097 (Fed. Cir. 1986) (“Non-obviousness cannot be established by attacking references individually where the rejection is based upon the teachings of a combination of references.”). Appellant next argues that Smith does not teach the “error response” limitation of claim 1. Appeal Br. 22. Claim 1 recites that “said error response comprises said controller operating said staple firing system in an operating mode which is suitable regardless of whether said first end effector or said second end effector is attached to the surgical instrument in order to perform said staple firing stroke.” The Examiner found this limitation taught by Smith’s disclosure that: When the microprocessor 2000 detects that a new part 2200 has been connected to the device 1, it runs an authentication routine. . . . If there is a difference between the hash code replies, then the part 2200 is rejected and the device is placed in a state where the part 2200 either cannot be used or can be used, but only after certain safeguards are met. Smith ¶181 (emphasis added); Final Act. 3 (quoting Smith ¶181). Appellant notes that Smith also teaches that data regarding the time, date, environment, etc. and characteristics of the unauthenticated part can be stored for later or simultaneous transmission to the manufacturer (or its agent) to inform the manufacturer that the user is attempting to use or has used an unauthorized part 2200 with the device. Appeal 2020-000017 Application 13/974,202 7 Smith ¶181; Appeal Br. 22. Appellant then argues that “[n]one of this information is used to alter the operating mode of the surgical instrument.” Appeal Br. 22. Appellant’s argument about the information not being used to alter the operating mode is incoherent. In any event, we agree with the Examiner’s finding that Smith’s disclosure that a rejected end effector “can be used, but only after certain safeguards are met” (Smith ¶181) meets the scope of claim 1’s recitation that “said controller operating said staple firing system in an operating mode which is suitable regardless” of which end effector is attached. Finally, Appellant argues the following: The Office’s conclusory statement that it would have been obvious to combine Smith '369 and Turner '405 simply to include an information identification system - is insufficient to support a prima facie conclusion of obviousness. The Office has not provided any sort of reasoning as to why someone skilled in the art would look to combine Smith '369 with Turner '405 - which, again, has absolutely nothing to do with the claimed invention - to arrive at Claim 1 of the Subject Application. Appeal Br. 23. Putting this argument in its best light, Appellant appears to challenge, not only the Examiner’s reason to combine, but possibly also whether Turner is analogous art. With respect to the former issue, it cannot be reasonably disputed that the Examiner provided a reason to substitute Turner’s authentication routine in Smith: “to verify the integrity of the data from the end effector[, which] would make the system more reliable and therefore better.” Final Act. 5. Appellant has not disputed this reasoning. Appeal Br. 23. Instead, Appellant has erroneously disputed that any reasoning was provided. Id. With respect to the latter issue, whether Turner is analogous art, Appellant wholly fails to explain why Turner would not be considered Appeal 2020-000017 Application 13/974,202 8 analogous art. A prior art reference is analogous art if it meets either criterion of In re Clay: “(1) whether the art is from the same field of endeavor, regardless of the problem addressed, and (2) if the reference is not within the field of the inventor’s endeavor, whether the reference still is reasonably pertinent to the particular problem with which the inventor is involved.” In re Clay, 966 F.2d 656, 658–59 (Fed. Cir. 1992). Although Turner is not from the field of surgical instruments, we find that Turner is analogous art under the second criterion of In re Clay. Turner discloses a “method . . . of calculating and verifying the integrity of data in a data communication system.” Turner, Abstract. This disclosure is reasonably pertinent to a particular problem with which the inventor was involved, as the Specification states, for example, the following: Such IDs may be, for example, RFIDs that the power management circuit 2006 read via a RFID transponder 2034. The RFID transponder 2034 may read RFIDs from the power sources that include RFID tags. The ID values may be read, stored in the memory 2030, and compared by the processor 2032 to a list of acceptable ID values stored in the memory 2030 or another store associated with the power management circuit 2006, to determine, for example, if the removable/replaceable primary power source 2002 associated with the read ID value is authentic and/or proper. In such circumstances, if the processor 2032 determines that the removable/replaceable component associated with the read ID value is not authentic, the power management circuit 2006 may be configured to prevent use of the instrument 10, such as by opening a switch (not shown) that would prevent power from being delivered to the instrument 10. Various parameters that the processor 2032 may evaluate to determine whether the component is authentic and/ or proper include date code, component model/type, manufacturer, regional information, and/or previous error codes, for example. Appeal 2020-000017 Application 13/974,202 9 Spec. ¶220. Although Appellant asserts that Turner “has absolutely nothing to do with the claimed invention” (Appeal Br. 23), Appellant has not argued, let alone substantiated, that Turner is not analogous art under the controlling legal test articulated in In re Clay. For the foregoing reasons, we affirm Rejection 1. Rejection 2 The Examiner rejected claims 11 and 12 as unpatentable over Smith, Turner, and Hueil. Final Act. 10. Appellant argues against this rejection solely on the basis that Hueil fails to cure the alleged deficiency in the rejection of claim 9 (Rejection 1) from which claims 11 and 12 depend. Appeal Br. 24–25. As Appellant does not establish any such deficiency in Rejection 1 as discussed above, Appellant likewise does not apprise us of error in Rejection 2. Accordingly, we affirm Rejection 2. Rejection 3 The Examiner rejected claims 6 and 14 as unpatentable over Smith, Turner, and Analog Dialogue. Final Act. 11–12. Appellant argues against this rejection on the basis that Analog Dialogue fails to cure the alleged deficiency in the rejection of claims 1 and 9 (Rejection 1), from which claims 6 and 14 respectively depend. Appeal Br. 25. However, Appellant does not establish any such deficiency in Rejection 1 as discussed above. Appellant also argues that the Examiner “has failed to provide any articulated reasoning or rational underpinning as to why a person skilled in the art would look to a reference [(i.e., Analog Dialogue)] which is entirely unrelated to surgical instruments, to arrive at the claimed subject matter of the Subject Application.” Id. This argument against the Examiner’s reliance on Analog Dialogue tracks an argument presented against Rejection 1 with Appeal 2020-000017 Application 13/974,202 10 respect to the Examiner’s reliance on Turner. Appellant’s argument here is likewise undeveloped and ultimately does not apprise us of error. Analog Dialogue, like Turner, is not directed to the field of surgical instruments. But that fact alone does not render it non-analogous art under the controlling legal test set forth, for example, In re Clay. Analog Dialogue relates to processors for handling advance RFID reader applications. Analog Dialogue, Title. The Examiner relies on its first paragraph merely for evidencing that “a radio-frequency identification (RFID) tag transmit information in the form of a bit stream to a RFID reader.” Final Act. 12 (citing Analog Dialogue ¶1). Accordingly, we affirm Rejection 3. Rejection 4 The Examiner rejected claims 7, 8, and 15–20 as unpatentable over Smith, Turner, Analog Dialogue, and Protocol. Final Act. 12. Appellant argues claim 17 separately from claims 7, 8, 15, 16, and 18–20. Appeal Br. 26–27. For claim 17, Appellant references and relies upon arguments already found unpersuasive above. Id. at 26. Appellant’s only additional argument for claim 17 is that Protocol “is also entirely unrelated to surgical instruments.” Again, such an assertion speaks only to the first criterion set forth in In re Clay. That is, Appellant again fails to argue, let alone substantiate, that a reference (here, Protocol) is not reasonably pertinent to a particular problem with which the inventor was involved. Appeal Br. 26. For claims 7, 8, 15, 16, and 18–20, Appellant relies exclusively on arguments already found unpersuasive above. Id. at 27. Accordingly, we affirm Rejection 4. Appeal 2020-000017 Application 13/974,202 11 SUMMARY Claims Rejected 35 U.S.C. § References/Basis Affirmed Reversed 1, 2, 5, 9, 10, 13, 21 103 Smith, Turner 1, 2, 5, 9, 10, 13, 21 11, 12 103 Smith, Turner, Hueil 11, 12 6, 14 103 Smith, Turner, Analog Dialogue 6, 14 7, 8, 15–20 103 Smith, Turner, Analog Dialogue, Protocol 7, 8, 15–20 Overall Outcome 1, 2, 5–21 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation